INOVIO Pharmaceuticals announces $75 million public stock offering
1 report, 1 independent
Updated Sun 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
INOVIO Pharmaceuticals announced an underwritten public offering of 58,747,235 shares of common stock and pre-funded warrants. The offering, which was filed with the Securities and Exchange Commission, is expected to raise approximately $75 million before expenses. The offering is scheduled to close on or about November 9, 2026.
From prnewswire.com
Why it matters
The public offering allows INOVIO Pharmaceuticals to raise significant capital to fund its operations and development of DNA medicines. The sale of common stock and warrants directly impacts the company's financial structure and market valuation.
From prnewswire.com
Who's involved
- Securities and Exchange CommissionRegulatory body receiving the public offering filing
Keep exploring
The entities involved
-
Securities and Exchange Commission
government agency of the Philippines